Application of a bioinformation digital platform for personalized treatment of cancer patients (using the example of the Onco Genotest company)

Diagnosis of oncological diseases is a complex process that combines knowledge in such diverse disciplines as biology, immunology, biophysics, cell biology, etc. Based on this knowledge, multidisciplinary specialists (pathomorphologists, biochemists, cytologists, geneticists, radiologists, etc.) must correctly diagnose the patient's disease. As a result of the research, the main factors have been identified that contribute to the increase in the incidence of cancer, the growth in the volume of scientific data, the emergence of new drugs and genetic solutions for molecular-targeted therapy, the expansion of opportunities to provide personalized care to patients, and the introduction of a multidisciplinary approach to diagnosis. The advantages of the bioinformation platform of the Onco Genotest company as a universal tool for obtaining more accurate diagnoses of patient diseases by oncologists are shown. Using a specific clinical case, an approach to implementing the principle of personalized medicine and precision oncology is described.